Home / Stocks / TCRX

TCRX insider trading

TScan Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$3.7M
Buys · last 90 days
0 · $0
Most recent buy
2025-12-23

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-23Lynx1 Capital Management LP
10% owner
Bought161,801$0.90$146k
2025-05-21Lynx1 Capital Management LP
10% owner
Bought2,588,794$1.20$3.1M
2024-12-16Lynx1 Capital Management LP
10% owner
Bought131,800$2.93$386k
2024-11-19Lynx1 Capital Management LP
10% owner
Bought947$4.34$4k
2024-09-24Klencke Barbara
Director
Bought5,000$5.29$26k

Most active insider buyers

InsiderRoleBuysTotal bought
Lynx1 Capital Management LP10% owner4$3.6M
Klencke BarbaraDirector1$26k

See TCRX on the chart

Every insider buy and sell for TCRX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.